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Abstract 
 
Introduction: Heightened concerns about industry influence on 
continuing medical education (CME) have prompted tighter controls on 
the management of commercial funding and conflict of interest. As a 
result, CME providers must closely monitor their activities and intervene 
if bias or noncompliance with accreditation standards is likely. Potential 
for industry influence can be difficult to assess at a stage in the planning 
process when mitigation strategies can assure balance and content 
validity. Few tools exist to aid providers in this regard.  
 
Methods: A 12-item instrument was designed to assess risk for 
commercial influence on CME. To determine reliability and validity, a 
cohort of experienced CME professionals applied the tool to standardized 
“cases” representing CME activities in the early stages of planning. 
Results were compared with the experts’ assignment of the same cases 
to one of four risk categories. A survey of study participants was 
conducted to ascertain usefulness and potential applications of the tool.  
 
Results: Analysis demonstrated strong intraclass correlation across 
cases (0.90), interrater reliability (94%), and correlation between 
assessment of risk with and without the tool (Spearman coefficient, 
0.93, p < 0.01; weighted kappa, 0.59). Participants found the tool easy 
to use and of potential benefit to their CME office.  
 
Discussion: The Consortium for Academic Continuing Medical Education 
(CACME) risk stratification tool can help CME providers identify activities 
that must be closely monitored for potential industry influence, remain 
aware of factors that place programming at risk for noncompliance with 
accreditation standards, and substantiate the allocation of resources by 
the CME office.  
 
Key Words: continuing medical education, commercial interests, standards 
for commercial support, risk stratification tool, risk assessment, ethical 
standards, Consortium for Academic Continuing Medical Education  
Introduction  
Increasing levels of commercial funding for continuing medical education 
(CME) in the United States have raised concerns about the effect of industry 
on the quality and scientific balance of physician education as well as the 
independence of the CME enterprise.
1–3 
In 2006, 61% of CME revenue in the 
United States was derived from commercial sources, such as the 
pharmaceutical and medical device industry.
4 
Given that CME participants 
often have difficulty determining the difference between commercial bias and 
expert personal opinion,
5 
educators must play an active role in assuring that 
programming is balanced and evidence-based. Standards promulgated by 
various accrediting organizations, including the Accreditation Council for 
Continuing Medical Education (ACCME),
6 
the American Academy of Family 
Physicians,
7 
and the American Medical Association,
8 
hold CME providers 
accountable for the scientific integrity of their programs. Despite the 
expenditure of considerable administrative resources to adhere to regulatory 
requirements,
5 
it is discouraging to recognize that 20% of ACCME-accredited 
organizations are in noncompliance with one or more elements of the 
Standards for Commercial Support (SCS).
9 
CME providers must develop 
rigorous methods to recognize, manage, and assess commercial influence. 
Tools developed for this purpose, such as surveys of participants’ 
perceptions of bias, are customarily used at the end of an activity when it is 
too late for providers to intervene.
10 
 
 
 
Risk stratification is a statistical process employed in medicine to determine 
factors associated with adverse clinical outcomes, so that practitioners can 
develop targeted interventions to mitigate their impact.
11,12 
For example, the 
identification of risk factors for coronary artery disease (e.g., hypertension, 
diabetes, hyperlipidemia, cigarette smoking) is used as a basis for initiating 
a variety of lifestyle modifications and medical interventions that can reduce 
morbidity and mortality rates.
11 
This approach has been employed in 
numerous other clinical conditions.
13–16 
Application of these principles to the 
CME enterprise offers the opportunity to prospectively identify factors that 
may adversely affect the balance and educational integrity of programming. 
Interventions can then be developed to maintain compliance with regulatory 
standards and, more importantly, provide effective learning experiences.  
 
 
In 1998, the Consortium for Academic Continuing Medical Education 
(CACME)
a 
began developing a risk stratification tool to assess potential for 
commercial influence. Using nominal group and Delphi techniques, four 
major factors contributing to risk were identified: (1) the nature of the 
activity’s content, (2) the amount and characteristics of commercial support, 
(3) the level of control of the CME office in planning and financial 
management, and (4) the potential influence of commercial entities on 
various stakeholders, such as course directors. Criteria for assessment of 
each of these factors were refined through pilot testing, resulting in a 12-
item instrument )Appendix). Numerical weighting of these items permitted 
calculation of an overall risk score, and ranges of scores were grouped into 
categories of low, moderate, high, and very high risk, with management and 
oversight processes developed for each level. Over time, results obtained 
through use of the tool were compared with actual monitoring and 
compliance issues of CACME activities, resulting in ongoing refinement of 
item weighting and operational definitions. Participating schools have 
routinely used the risk tool at the beginning of the planning process for all 
activities except regularly scheduled conferences. Strategies to mitigate the 
risk identified by the tool have included denial of certification, enhanced 
monitoring, more rigorous resolution of conflict of interest, and increased 
involvement of the CME office in educational design and logistical support. 
Ongoing quality assurance reviews have demonstrated consistent 
compliance of activities with the ACCME’s Standards for Commercial 
Support.  
 
Methods  
 
The usefulness of the tool in the CACME institutions stimulated interest in its 
dissemination to other CME providers. In order to enhance understanding of 
the value of the instrument, a study was conducted to determine whether a 
tool based on the principles of risk stratification, applied early in the 
planning process, could reliably identify issues that place CME activities at 
risk for commercial influence. To address this question and gain some 
understanding of the validity of the tool, we asked experienced CME 
providers, all of whom were knowledgeable about ACCME standards, to 
assign a set of CME activity “cases” to one of four risk categories (low, 
moderate, high, and very high). We compared these assessments to scores 
obtained when the same individuals applied the risk tool to the cases (Figure 
1).  
 
 
Development of Standardized Cases  
 
To provide a standardized evaluation environment, the “cases” were 
developed to represent data commonly available early in the CME planning 
process. Although these cases were based on actual CACME programs, some 
characteristics were modified to create representation among the four risk 
categories (low, moderate, high, and very high). Cases were placed into a 
structured format that included a general description of the proposed activity 
and details about the budget, funding sources, management, meals, social 
events, and relationships with industry (information that would normally be 
available early in the planning process). Every option for each of the 12 
items included in the risk stratification tool was represented in at least two 
of the cases included in the study. Preliminary evaluation of the cases for 
test-retest reliability was conducted using CACME deans, administrators, and 
staff who rated the cases on three separate occasions using the risk 
stratification tool. As a result of this exercise, modifications were made to 
improve the clarity and completeness of the information provided, yielding a 
total of 36 cases (9 in each risk category).  
 
 
Design  
 
On the basis of power calculation, it was determined that at least 12 ratings 
per case using the tool would be required to achieve statistically meaningful 
results. Study participants, who were each assigned 24 cases representing 
various levels of risk for commercial influence, were divided into two groups. 
Group 1 participants were sent the cases along with the risk stratification 
tool (without the associated numerical ratings), operational definitions for 
each of the 12 items, and two “practice cases” to familiarize them with use 
of the instrument. The individuals were asked to apply the tool to the cases 
and return all materials to the study team. Three weeks later, participants 
received the same cases (in different order) and were asked to assign them 
to one of four risk categories. Operational definitions of each category were 
provided, along with two “practice cases.” Group 2 received the cases along 
with the risk categories first and then repeated the exercise 3 weeks later 
using the risk stratification tool. After the second assessment, all participants 
received a 17-item survey using a 5-point Likert scale to assess perceptions 
of benefits, usability, and limitations of the tool.  
 
 
Study Participants  
 
A convenience sample of 22 CME professionals from across the United States 
was invited to participate. Of these, 18 agreed. Participants had an average 
of 13.8 years of experience in CME and worked in a variety of institutional 
settings. Eleven were ACCME surveyors and 2 were ACCME staff. None of 
them had ever seen or used the risk stratification tool. A $50 honorarium 
was offered to each participant for completion of the study.  
 
 
Statistical Analysis  
 
Descriptive statistics were used to report the characteristics and tabulate the 
responses of study participants. Assessment of the tool’s reliability was 
determined by calculation of the intraclass correlation coefficient across the 
36 cases. Interrater reliability was also calculated and expressed in terms of 
a mean value for each item and for all items.  
 
To assess the tool’s validity, total risk stratification scores were correlated 
with the assigned risk categories across the 36 cases. Results were 
expressed in terms of the Spearman correlation coefficient, which is a 
correlation between the level of risk as determined by the tool and the 
assigned risk categories across all cases. Weighted kappa, which is ordinarily 
considered to be a measure of consistency assessing agreement among 
raters extending beyond chance, was employed to assess validity. Validity 
was determined by consistency between the total risk score and the 
participants’ assignments to a risk category without benefit of the tool.  
 
To assess the tool’s usefulness, Likert scores were tabulated for each survey 
item and the mean score was calculated for each. Analyses were performed 
with Stata (StataCorp, College Station, TX) and SAS (SAS Institute, Cary, 
NC) in the Data Center at the University of Pittsburgh Center for Research 
on Health Care.
 
Results  
 
All participants completed the study. One set of data was incomplete and 
therefore unusable. The reliability of the tool among the different raters was 
strong. The intraclass correlation coefficient was 0.90, based on 36 cases 
(Table 1). Interrater reliability was calculated by the average agreement for 
each item. Results indicated strong interrater reliability of the tool, with an 
average agreement of 94% for all items (standard deviation = 9.27). The 
two items with the lowest degrees of reliability were the delegation of 
logistical responsibilities to another party (89%) and the level of 
involvement of a commercial supporter in suggesting topics (90%). Each of 
the remaining items showed greater than 90% agreement.  
 
In order to assess association and bias, we calculated the percentage 
agreement across raters for each of the cases. Across all 36 cases, the 
percentage agreement ranged from 85% to 99%, with an average 
agreement of 94%. This result demonstrates that the differences in scores 
were not attributable to the differences among the raters.  
 
The validity of the tool was assessed using two methods. First, we calculated 
the correlation across the 36 cases between the tool and the subjective 
rating of the cases. Because of the small sample size, the four risk 
categories were collapsed to two, combining the low and moderate levels 
(low risk) and the high and very high levels (high risk). Using this 
methodology, the Spearman correlation coefficient was 0.93 ( p < 0.01), 
indicating a good correlation between the categories determined through use 
of the risk score and those assigned by the raters. Second, we estimated a 
weighted kappa to determine the extent to which the overall score obtained 
through use of the tool is consistent with the participants’ categorical 
assignments. To estimate the kappa, 24 ratings for each case were used (12 
ratings using the tool and 12 from category assignment), yielding a sample 
size of 408.
b 
The correlation between the total risk score determined by the 
tool and level of risk assigned by the raters was strong. The results of the 
weighted kappa also showed positive results with a kappa of 0.59. A kappa 
between .40 and .60 is considered reasonable agreement.
17 
Thus the kappa 
score indicates that the assessment of risk obtained through utilization of 
the tool is on par with that obtained utilizing expert judgment of the study 
participants (expert CME professionals).  
 
 
Of the 18 participants, 17 (94%) submitted complete rating data and 15 
(83%) returned surveys. Survey responses (TABLE 2) indicated that the tool 
has clear operating definitions (mean score of 4.0 on a 5-point Likert scale), 
can be helpful in allocating resources to high-risk activities (4.20), has 
potential use for teaching staff about standards for commercial support 
(4.47), and can assist CME professionals in thinking about issues that affect 
compliance with the Standards for Commercial Support (4.67). Fourteen of 
15 respondents agreed or were neutral about the potential use of the tool by 
the ACCME to select files for accreditation surveys, but 5 indicated that they 
would not want to share such information with the ACCME.  
 
 
Discussion  
 
Under increased pressure to prevent industry influence, CME providers must 
develop mechanisms for consistently identifying and managing vulnerable 
activities. Risk stratification methods have been employed in multiple areas 
of health care and in other disciplines. However, a review of the literature 
reveals only one article in which these methods were used to assess 
educational outcomes.
18 
This study demonstrates a way to apply risk 
stratification principles to assess the potential for a CME activity to be 
influenced by industry, and therefore noncompliance with ACCME Standards 
for Commercial Support. Our results indicate that the CACME risk 
stratification tool provides a mechanism to estimate risk that is reliable, 
potentially valid (as judged by the standard of expert assessment of risk), 
and useful to CME providers.  
 
Two principles of risk assessment are particularly relevant to CME. One is 
the prediction of risk, with an emphasis on identification of risk factors and 
stratification of overall risk. The other is the management of risk, with an 
emphasis on risk reduction.
17 
The CACME tool addresses both principles. 
First, by helping CME professionals identify factors that can contribute to 
noncompliance with standards, the tool prompts data collection about 
specific program issues that are critical to maintenance of compliance. 
Second, once risk factors have been identified, planners can develop 
strategies to mitigate these factors. The higher the category of risk, the 
greater the need for “risk management,” including such actions as stringent 
monitoring, review of documentation, and allocation of resources and 
personnel to ensure compliance. Thus, the CACME risk stratification tool 
provides a prediction that can influence the decision about whether to certify 
a given CME activity and can guide management throughout planning and 
development. In addition, the tool may be useful for training CME staff and 
educating activity directors, joint sponsors, funders, and other individuals 
who contribute to the implementation process. Finally, compilation of 
aggregate risk scores and data about individual activities allows providers to 
evaluate their overall CME program.  
 
CACME’s work demonstrates the value of multiinstitutional collaboration in 
addressing complex issues associated with educational planning and 
certification. In developing the tool, the iterative process we employed drew 
on the expertise of leaders from all member schools. It is unlikely that any 
single individual or institution could have developed such a tool in isolation. 
Applying the tool across the consortium allowed us to monitor the 
performance of the individual members and the consortium as a whole. This, 
in turn, expanded CACME’s ability to use the tool for decision making, 
program planning, and evaluation.  
 
Limitations  
 
This study used CME experts to determine a “gold standard” of potential risk 
(assignment of cases to a risk category) against which the tool was 
measured. The ideal design to test our instrument would be a naturalistic 
study in which activities were assessed with the tool and then allowed to 
proceed without any intervention by the accredited provider (analogous to 
the natural course of disease), with a follow-up evaluation to determine 
whether commercial influence or noncompliance with accreditation standards 
was present. However, this situation does not occur in the real world 
because accredited providers do intervene to assure compliance. 
Determination of risk factors in the clinical setting is customarily 
accomplished through the use of large epidemiologic studies. Such an 
approach is beyond the scope of this study. We relied on participants’ 
experience as providers and their knowledge of accreditation requirements 
to make accurate determinations of potential risk and recognize that this 
approach limits conclusions about the validity of the tool. However, the 
validity of the instrument demonstrated in this study has been supported by 
experience within CACME that indicates frequent compliance issues in 
activities with high risk scores. 
 
Another concern is that simulated cases were used rather than real activity 
files. Although the cases were based on actual CME programs, several were 
modified to represent high-risk activities and to ensure a balanced number 
of activities in all four risk categories. While this method may not reflect the 
actual case mix of an accredited CME provider, we wanted to emphasize 
detection of “outlier” high-risk activities; although they are uncommon, it is 
critically important to identify them in order to maintain compliance. We also 
recognize that the information was provided in a structured and consistent 
fashion, addressing the elements of the activity appropriate to the items 
contained within the tool. In the day-to-day practice of CME, some data may 
not be readily available early in the planning process and the individuals 
using the tool may not be knowledgeable about some of the factors (such as 
previous experience with a joint sponsor or logistical partner). As a result, 
the reliability of the tool may be lower than observed in this study.  
 
The size and characteristics of our study sample are relatively limited by the 
number of available CME experts. Because of the size, the four risk 
categories were collapsed into two for purposes of one of the measures of 
validity, limiting conclusions about the discriminatory capacity of the tool 
across the wide range of risk. The use of seasoned CME professionals in this 
study also raises questions about the ability to generalize use of the tool 
among CME providers with varying backgrounds and experience. Long-
standing implementation within the four CACME institutions indicates that 
staff at all levels can use the instrument with reliable results. In addition, 
study participants indicated that the tool would be useful in their offices.  
 
It is possible that some important risk factors are not included in our tool. 
During development, some factors that were difficult to quantify or 
operationally define were excluded. Additional use and evaluation of the tool 
may permit incorporation of such factors. 
 
Conclusions  
 
The CACME Risk Stratification Tool supports the prospective identification of 
CME activities that may be at risk for commercial influence. The 12-item tool 
is easy to use and allows users to categorize each CME activity’s potential for 
noncompliance as low, medium, high, or very high. The results of a case-
based crossover study confirm that the tool is reliable and may have 
predictive value in terms of risk for commercial influence. A survey of users 
indicates that it would be useful for objectively assessing a CME program in 
the planning stage. In addition, the tool can assist in teaching staff about 
standards for commercial support of CME activities, help individuals identify 
issues that affect compliance with the standards, and support administrators 
in allocating resources to mitigate the risks of noncompliance. Through the 
use of this tool, CME providers can define rational and consistent strategies 
for certification and management of activities. Such an approach may be
particularly beneficial in large, decentralized programs that delegate many of 
these responsibilities to individuals outside the CME office.  
 
There is increasing public demand for transparency and management of 
relationships between health care organizations and industry.
19,20 
It is 
critically important for CME providers to assure that educational 
programming is evidence-based, balanced, free of commercial influence, and 
effective. Instruments such as the risk stratification tool provide an objective 
and systematic means to assess the level of involvement by external entities 
prospectively in order to allocate appropriate resources to foster compliance 
with regulatory standards and preserve educational integrity.  
 
Lessons for Practice  
 
• It is incumbent upon CME providers to implement mechanisms to 
assure that activities are free of commercial influence and bias.  
 
• Risk stratification provides a mechanism to identify commercial 
influence in CME and mitigate risk for noncompliance with ACCME 
Standards for Commercial Support.  
 
• A risk stratification tool has proved reliable, valid, and useful in 
identifying CME activities at risk for commercial influence.  
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Notes  
 
a. CACME members consisted of Jefferson Medical College, Penn State 
College of Medicine, Temple University, and the University of 
Pittsburgh. In 2005, CACME was disbanded as an accredited 
consortium, but the four schools continue to collaborate on this and 
other projects.  
 
b. Traditionally kappa is considered a measure of consistency. However, 
when one of those measures is the standard by which the other is 
judged (in this case, the expert judgment of risk), one can infer the 
validity of the second measure to the extent that it is consistent with 
that standard.  
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Appendix: CACME Risk Stratification Tool  
 
NAME OF ACTIVITY: _________________________________________ 
  
1. Joint sponsorship 
Activity is directly sponsored, no joint sponsors: 0 
Activity is jointly sponsored and all joint sponsors are nonprofit 
organizations: 1 
Activity is jointly sponsored and some or all joint sponsors are for-profit 
organizations: 2 
 
2. Experience with jointly sponsoring organizations 
Activity is directly sponsored, no joint sponsors: 0 
Positive experience with all jointly sponsoring organization(s): -1 
No prior experience with one or more of the jointly sponsoring 
organizations: 1 
Some negative experiences with one or more of the jointly sponsoring 
organizations: 3 
 
3. Commercially supported activity with a standard curriculum 
delivered at multiple locations 
No commercial support: 0 
Commercial support but the activity does not feature multiple 
presentations of the same curriculum at different locations: 0 
Commercially supported activity with multiple presentations of the 
same curriculum at different locations: 3 
 
4. Responsibility for course logistics 
Handled entirely by staff from the CME office: 0 
Some or all responsibilities delegated by the CME office to one or 
more entities: 1 
Some or all responsibilities delegated by a joint sponsor to one or 
more entities: 2 
Some or all of logistics performed by an organization suggested or 
chosen by a commercial supporter:3 
 
5. Experience with the entity(ies) external to the CME office 
responsible for some or all of logistics 
Not applicable (all logistics handled by the CME office):0 
Positive experience working with the entity(ies): -1 
No experience working with the entity(ies):1 
Negative experience with the entity(ies):3 
 
6. Responsibility for funds management 
The CME activity has no income or expenses: 0 
Funds management handled entirely by staff from the CME office: 0 
Some or all funds management handled by a not-for-profit entity 
outside the CME office: 2 
Some or all funds management handled by a for-profit entity external 
to the CME office: 3 
 
7. Number of commercial supporters 
No commercial support for the course: 0 
Two or more commercial supporters: 2 
One commercial supporter with whom the accredited provider has 
worked and has had good experiences: 3 
One commercial supporter with whom the accredited provider has 
never worked: 4 
One commercial supporter with whom the accredited provider has 
worked and has had negative experiences: 5 
 
8. Anticipated amount of commercial support as a percentage of 
the anticipated total revenue 
No commercial support: 0 
Up to 50% of course revenue will be from commercial support: 1 
51% to 99% of course revenue will be from commercial support: 3 
100% of course revenue will be from commercial support: 4 
 
9. Level of involvement of any commercial supporter(s) (choose 
all that apply): MAXIMUM SCORE OF 3  
No commercial support: 0  
Commercial support but no involvement of any commercial supporters 
with the logistical or educational aspects of the activity: 1  
Assistance from the commercial supporter with marketing: 1 
Suggestion from the commercial supporter for course location: 1 
Recommendation from the commercial supporter of potential 
participants: 1  
Recommendation from the commercial supporter of the topic area: 1 
Recommendation from the commercial supporter of one or more 
speakers: 1  
 
10. Anticipated amount of exhibit funds as a percentage of 
anticipated total revenue of the activity  
There will be no exhibit revenue: 0  
Up to 50% of course revenue will be from exhibit revenue: 1  
51% to 100% of course revenue will be from exhibit revenue: 2  
 
11. Discussion of experimental and/or off-label uses  
Primary intent does not involve the discussion of experimental and0or 
off-label uses: 0  
Primary intent does involve the discussion of experimental and0or off-
label uses: 2  
 
12. Relationships between the course director(s) and industry that 
might affect the scientific balance of the content  
No relationships exist between course director(s) and industry that are 
likely to affect the scientific balance: 0  
Relationships exist between course director(s) and industry that are 
likely to affect the scientific balance of the activity: 2  
 
TOTAL SCORE  ________ 
 
RISK CATEGORY: 
 
____ LOW (≤ 2)  
____ MODERATE (3 TO 11)  
____ HIGH (12 TO 19)  
____ VERY HIGH: (≥ 20)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures and Tables 
 
 
Figure 1. Study design.  
 
 
Table 1. Summary of Statistical Analysis  
 
Reliability Validity 
Average 
agreement  
Intraclass 
correlation  
coefficient, 
single rater  
Spearman 
correlation  
coefficient  
Weighted 
kappa  
 
94%  
(standard 
deviation = 
9.27)  
 
.9030  
p = 0.000  
(n = 36)  
 
0.932  
p < 0.01  
(n = 36)  
 
0.5866  
p = 0.0263  
(n = 408)  
 
 
 
 
Table 2.  Participant Survey Results  
 
1 The risk stratification tool makes me think about issues that affect 
compliance with the Standards for Commercial Support 
4.67 
2 The risk tool is difficult to use. 1.80 
3 The operational definitions for the elements of the risk 
stratification tool are clear and easy to understand. 
4.00 
4 Use of the risk stratification tool is time consuming. 2.67 
5 Routine use of the risk stratification tool would help my CME 
department decide which activities to certify. 
3.73 
6 Routine use of the risk stratification tool would assist my CME 
office in allocating resources to activities at higher risk of 
noncompliance with ACCME requirements. 
4.20 
7 The risk stratification tool would be useful for teaching staff about 
issues associated with the Standards for Commercial Support. 
4.47 
8 It would take a long time to train my staff to use the risk 
stratification tool. 
2.13 
9 Results obtained through the use of the risk stratification tool 
would be useful to the ACCME in deciding which files to review 
during accreditation surveys.  
3.60 
10 I would not want to share the risk information obtained through 
use of the risk stratification tool with the ACCME. 
2.93 
11 Information obtained through use of the risk stratification tool 
would be helpful in justifying to course directors and joint 
sponsors why certain requirements of the CME office are 
necessary.  
4.47 
12 Use of the risk stratification tool would help to justify why the CME 
department assesses higher fees for certain activities. 
4.00 
13 The concept of a risk stratification tool is potentially very valuable 2.00 
but the instrument provided is not adequate.  
14 Certain key elements are missing from the risk stratification tool 
that was provided. 
2.54 
15 Use of the risk stratification tool adds little to my own subjective assessment 
of an activity’s potential risk for noncompliance with the ACCME Standards 
for Commercial Support. 
2.33 
16 I would like to use the risk stratification tool routinely in my CME 
office. 
4.00 
17 Information obtained through use of the risk stratification tool 
would be helpful in explaining to industry representatives why 
certain requirements of the CME office are necessary. 
4.27 
Note: 1 = Strongly disagree; 2 = Disagree; 3 = Neutral; 4 = Agree; 5 = 
Strongly agree.  
 
